Related Experiment Video
Updated: Feb 17, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
Barriers to clinical adoption of next-generation sequencing: a policy Delphi panel's solutions
Donna A Messner1, Pei Koay1, Jennifer Al Naber1
1Center for Medical Technology Policy, Baltimore, MD 21202, USA.
Aim:
Identify solutions to the most important policy barriers to the clinical adoption of next-generation sequencing.
Materials & Methods:
Four-round modified policy Delphi with a multistakeholder panel of 48 experts. The panel deliberated policy solutions to (previously reported) challenges deemed most important to address.
Results:
The group advocated using consensus panels to promote consistency in payer policies and to standardize test reporting, and favored making genomic data-sharing a condition of regulatory clearance, certification, or accreditation processes. They were split on the role of US FDA.
Conclusion:
Panelists found common ground on solutions for health plan coverage policy consistency, data-sharing, and standardizing reporting, but were sharply divided on the role of the FDA in mitigating risks to patients.
More Related Videos
Related Concept Videos
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Sanger Sequencing
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Maxam-Gilbert Sequencing
Challenges of the Maxam-Gilbert Method
The...

